Diffuse, persistent, pruritic maculopapular rash developed 10 days after tocilizumab treatment
General consensus supporting early multimodality treatment for infantile hemangiomas of the nose
The team found no significant differences between the three groups of children who received topical steroid, emollient, or placebo in terms of Patient Oriented Eczema Measure scores.
Children with protective bedding went much longer before having an exacerbation that led to an emergency room visit or hospital stay for treatment with systemic corticosteroids.
Findings based on number of symptom-free days for daily versus as-needed treatment
AAN 2016 General News
Treatment with oral dexamethasone for 4 days significantly improved pain levels in the majority of outpatients with status migrainosus, a retrospective chart review presented at the 68th AAN Annual Meeting has found.
Ten days of treatment linked to increase in peak thrombin, velocity index, PAI-1, and vWF
ACR/ARHP Annual Meeting 2015
Ustekinumab (UST) benefits patients with psoriatic arthritis (PsA) with spondylitis and peripheral joint involvement, according to an post-hoc analysis of results from the PSUMMIT 1 & 2 phase 3 double-blind, placebo-controlled clinical trials, reported at the 2015 ACR/ARHP Annual Meeting.
Dermatologist, allergist, primary care doctors failed to identify etiology of rash over several months
Greater risks seen for those exposed to steroid drugs in the womb